相关临床试验
0
0 进行中
药物批准
4
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
**INDICATIONS** In general medicine: - blood loss through fragile capillaries - menorrhagia (heavy periods) with no detectable organic cause - in general or specialized surgery (ENT, ophthalmology, gynaecology): reduction of blood loss during operations, particularly diffuse haemorrhage, patients treated with anticoagulants.
暂无资讯文章
